Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

52.80 -0.96 (-1.79%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
April 14, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4/A
Source: SEC/Edgar
February 19, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 05, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
December 09, 2018
Form 4
Source: SEC/Edgar
October 02, 2018
Form 3
Source: SEC/Edgar
September 13, 2018
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Copyright © 1995-2016 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.